Researches on Indigenous System of Medicine have long been needed by modern scientists to confirm the various claims made by the practitioners of holistic system in terms of scientific rational. Nature provides valuable clues that can help mankind find cures for the most challenging diseases.
Care formulation labs emphasized on the authenticity of Ayurveda and always strived hard to unearth the hidden facts of this system of medicine through Research & Development practices with an aim to design and develop, standardize safe herbal formulation with superiority over the conventional brand in the form of Patent & Proprietary formulation.
Research and development (R&D) refers to the activities companies undertake to innovate and introduce new products and services. It is often the first stage in the development process. The goal is typically to take new products and services to market and add to the company’s bottom line.
Companies across all sectors and industries undergo R&D activities. Corporations experience growth through these improvements and the development of new goods and services. Pharmaceuticals, semiconductor, and software/technology companies tend to spend the most on R&D.
The term R&D is widely linked to innovation both in the corporate and government world or the public and private sectors. R&D allows a company to stay on top of its competition. Without an R&D program, a company may not survive on its own and may have to rely on other ways to innovate such as engaging in mergers and acquisitions (M&A) or partnerships. Through R&D, companies can design new products and improve their existing offerings.
R&D is separate from most operational activities performed by a corporation. The research and/or development is typically not performed with the expectation of immediate profit. Instead, it is expected to contribute to the long-term profitability of a company. R&D may lead to patents, copyrights, and trademarks as discoveries are made and products created.
Unlike death and taxes, there are no guarantees with hoped-for R&D outcomes, so a company might spend a large amount of money in the search for a faster or better way to do something or a medication that’s better than the one they’re already manufacturing, and never get a return on the investment. R&D is not an asset, then. It’s an expense.
For that reason, general accounting standards and practices dictate that most (but not all) costs associated with R&D be charged to expense as incurred.